EligibleTrials

Trans-arterial Embolization for the Treatment of Facet Pain Due to Facet Arthropathy

Recruiting · NCT06965452 · Interventional (participants receive a specific treatment) · Lead sponsor: Northwell Health

View the official record on ClinicalTrials.gov →
Osteoarthritis

Interventions studied

Spinal angiography and embolization/ Embozene Microspheres

What this trial is about

This single-site, single-arm study evaluates the feasibility, safety, tolerability, and efficacy of trans-arterial embolization (TAE) using Embozene microparticles for treating facetogenic pain due to facet arthropathy (osteoarthritis of the facet joints) in the lumbar spine.

Who can take part

Age range
18 Years to 85 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed across 1 US state.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.